Biotech · Private company
Ambros Therapeutics, Inc.
Track this companyFree. Adds Ambros Therapeutics, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials33 recruiting or active
Pipeline programs1From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline1
- NeridronatePhase 3 · Complex Regional Pain Syndrome Type IClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials3
- Phase 3, Open-Label Extension Study of AMBTX-01 (Neridronate) for Complex Regional Pain Syndrome Type 1PHASE3 · RECRUITING · started Oct 13, 2026ClinicalTrials.gov NCT07857733 · fetched Nov 12, 2026
- CRPS-RISE Outcomes RegistryRECRUITING · started Sep 17, 2026ClinicalTrials.gov NCT07811362 · fetched Nov 12, 2026
- Evaluation of IV AMBTX-01 (Neridronate) for Treatment of CRPS Type 1 (CRPS-RISE)PHASE3 · RECRUITING · started Apr 14, 2026ClinicalTrials.gov NCT07210515 · fetched Nov 12, 2026